Insider · CIK 0001298900

Titus Gary

Reports to the SEC for 4 companies · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001298900

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2016-06-17	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chairman and Secretary	AAward	+157K sh	—	—	156,750
2015-09-18	IMUCEOM Pharmaceutical Holdings, Inc.A Award	Director, Chairman and Secretary	AAward	+10K sh	—	—	28,000
2015-09-18	IMUCEOM Pharmaceutical Holdings, Inc. · Common StockA Award	Director, Chairman and Secretary	AAward	+10K sh	—	—	10,000
2015-06-26	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chairman and Secretary	AAward	+75K sh	—	—	75,000
2013-12-20	IMUCEOM Pharmaceutical Holdings, Inc.P Purchase	Director, Chairman and Secretary	PPurchase	+100 sh	$0.78	+$77.99	100
2013-12-20	IMUCEOM Pharmaceutical Holdings, Inc.P Purchase	Director, Chairman and Secretary	PPurchase	+17.9K sh	$0.78	+$14K	18,000
2013-09-20	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chairman and Secretary	AAward	+65K sh	—	—	65,000
2013-03-07	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chairman and Secretary	AAward	−21.9K sh	—	—	21,945
2013-03-07	IMUCEOM Pharmaceutical Holdings, Inc. · Stock Option (right to buy)A Award	Director, Chairman and Secretary	AAward	−11.3K sh	—	—	11,342
2012-06-15	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	+37K sh	$0.95	+$35.1K	74,049
2012-06-15	SCICLONE PHARMACEUTICALS INCS Sale	Senior VP Finance & CFO	SSale	−37K sh	$6.99	−$258K	37,095
2012-06-15	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	+29.6K sh	$0.95	+$28.1K	66,719
2012-06-15	SCICLONE PHARMACEUTICALS INCS Sale	Senior VP Finance & CFO	SSale	−29.6K sh	$6.99	−$207K	37,095
2012-06-15	SCICLONE PHARMACEUTICALS INCIncentive Stock Option (right to buy)M Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	−37K sh	—	—	98,017
2012-06-15	SCICLONE PHARMACEUTICALS INCIncentive Stock Option (right to buy)M Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	−29.6K sh	—	—	68,393
2012-06-14	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	+15K sh	$0.95	+$14.3K	52,124
2012-06-14	SCICLONE PHARMACEUTICALS INCS Sale	Senior VP Finance & CFO	SSale	−15K sh	$7.05	−$106K	37,095
2012-06-14	SCICLONE PHARMACEUTICALS INCIncentive Stock Option (right to buy)M Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	−15K sh	—	—	134,971
2012-05-31	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+261 sh	$3.84	+$1,002.762	37,095
2012-05-14	SCICLONE PHARMACEUTICALS INCM Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	+9,357 sh	—	—	36,834
2012-05-14	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitM Exercise/Conversion	Senior VP Finance & CFO	MExercise/Conversion	−9,357 sh	—	—	28,070
2012-03-15	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP Finance & CFO	AAward	+150K sh	—	—	150,000
2012-02-29	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+241 sh	$3.78	+$911.583	27,477
2011-11-30	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+241 sh	$3.78	+$911.583	27,236
2011-08-31	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+229 sh	$3.98	+$910.962	26,995
2011-08-18	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+1,075 sh	$4.65	+$4,998.75	26,766
2011-06-15	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+2,000 sh	$4.96	+$9,919.8	25,494
2011-06-15	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+197 sh	$4.93	+$971.19	25,691
2011-05-31	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+258 sh	$3.60	+$927.639	23,494
2011-05-27	SCICLONE PHARMACEUTICALS INCRestricted Stock UnitA Award	Senior VP Finance & CFO	AAward	+37.4K sh	—	—	37,427
2011-05-12	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock OptionA Award	Senior VP Finance & CFO	AAward	+200K sh	$5.13	+$1.03M	200,000
2011-02-28	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+411 sh	$3.29	+$1,351.985	23,236
2010-11-30	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+269 sh	$2.15	+$578.485	22,825
2010-08-31	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+431 sh	$2.05	+$882.904	22,556
2010-05-11	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+2,500 sh	$3.39	+$8,475	22,125
2010-03-05	SCICLONE PHARMACEUTICALS INCNon-Qualified Stock Option (right to buy)A Award	Senior VP Finance & CFO	AAward	+100K sh	—	—	100,000
2009-05-22	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+1,625 sh	$1.75	+$2,843.75	16,625
2009-05-22	SCICLONE PHARMACEUTICALS INCP Purchase	Senior VP Finance & CFO	PPurchase	+3,000 sh	$1.73	+$5,190.9	19,625
2008-01-02	KOSAN BIOSCIENCES INCRestricted Stock UnitsA Award	Sr. VP and CFO	AAward	+32.2K sh	—	—	32,200
2006-08-25	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Acct.Officer	MExercise/Conversion	+10K sh	$9.21	+$92.1K	12,633
2006-08-25	ORKAOruka Therapeutics, Inc.S Sale	Chief Acct.Officer	SSale	−10K sh	$20.00	−$200K	2,633
2006-08-25	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Acct.Officer	MExercise/Conversion	+10K sh	$9.67	+$96.7K	12,633
2006-08-25	ORKAOruka Therapeutics, Inc.S Sale	Chief Acct.Officer	SSale	−10K sh	$20.00	−$200K	2,633
2006-08-25	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Acct.Officer	MExercise/Conversion	+20K sh	$9.16	+$183K	22,633
2006-08-25	ORKAOruka Therapeutics, Inc.S Sale	Chief Acct.Officer	SSale	−20K sh	$19.88	−$398K	2,633
2006-08-24	ORKAOruka Therapeutics, Inc.M Exercise/Conversion	Chief Acct.Officer	MExercise/Conversion	+15K sh	$9.82	+$147K	17,633
2006-08-24	ORKAOruka Therapeutics, Inc.S Sale	Chief Acct.Officer	SSale	−15K sh	$19.50	−$293K	2,633
2005-02-23	ORKAOruka Therapeutics, Inc.P Purchase	Chief Acct.Officer	PPurchase	+1,500 sh	$7.51	+$11.3K	1,879
2005-01-07	ORKAOruka Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Acct.Officer	AAward	+39.2K sh	—	—	39,167
2005-01-07	ORKAOruka Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	Chief Acct.Officer	AAward	+10.8K sh	—	—	10,833

Recent filings

Accepted (ET)
Jun 214
ImmunoCellular Therapeutics, Ltd.0001209191-16-129044
SEC(opens sec.gov)
Sep 224
ImmunoCellular Therapeutics, Ltd.0000899243-15-005203
SEC(opens sec.gov)
Jun 304
ImmunoCellular Therapeutics, Ltd.0001209191-15-057492
SEC(opens sec.gov)
Dec 204
ImmunoCellular Therapeutics, Ltd.0001181431-13-064026
SEC(opens sec.gov)
Sep 244
ImmunoCellular Therapeutics, Ltd.0001181431-13-050443
SEC(opens sec.gov)
Mar 114
Titus Gary0001181431-13-016069
SEC(opens sec.gov)
Jun 184
Titus Gary0001298900-12-000006
SEC(opens sec.gov)
May 164
Titus Gary0001298900-12-000004
SEC(opens sec.gov)

Companies

Address

950 TOWER LANE, SUITE 900

FOSTER CITY, CA, 94404